HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Pierantozzi Selected Research

Deep Brain Stimulation

5/2011The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus.
11/2010Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine.
10/2010Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease.
4/2010Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes: a target-specific effect or response to a low-frequency pattern of stimulation?
8/2008Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?
1/2006Deep brain stimulation in Parkinson's disease patients: biochemical evidence.
1/2002Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study.
2/2001Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Pierantozzi Research Topics

Disease

23Parkinson Disease (Parkinson's Disease)
08/2014 - 02/2001
3Tremor (Tremors)
12/2012 - 08/2008
2Alzheimer Disease (Alzheimer's Disease)
06/2015 - 10/2004
2Cognitive Dysfunction
06/2015 - 01/2002
2Disorders of Excessive Somnolence (Hypersomnia)
12/2006 - 01/2005
1Dyskinesias (Dyskinesia)
04/2013
1Gambling (Pathological Gambling)
11/2010
1Duodenitis
06/2006
1Gastritis
06/2006
1Sleepiness
01/2005
1Dementia (Dementias)
10/2004
1Frontotemporal Dementia (Semantic Dementia)
10/2004
1Infections
02/2001
1Parkinsonian Disorders (Parkinsonism)
08/2000

Drug/Important Bio-Agent (IBA)

10Levodopa (L Dopa)FDA LinkGeneric
04/2013 - 02/2001
3Pramipexole (Mirapex)FDA LinkGeneric
11/2010 - 04/2003
3ApomorphineFDA Link
09/2002 - 11/2001
2Dopamine (Intropin)FDA LinkGeneric
04/2013 - 08/2000
2CabergolineFDA LinkGeneric
12/2006 - 01/2005
1Amyloid (Amyloid Fibrils)IBA
06/2015
1Proteins (Proteins, Gene)FDA Link
06/2015
1Biomarkers (Surrogate Marker)IBA
06/2015
1Lactic Acid (Lactate)FDA LinkGeneric
06/2015
1rasagiline (Azilect)FDA Link
08/2014
1Tetrabenazine (Nitoman)FDA Link
04/2013
13-Iodobenzylguanidine (Iobenguane)IBA
12/2012
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
11/2011
1Guanosine Monophosphate (5' Guanylic Acid)IBA
05/2011
1Dopamine Agonists (Dopamine Agonist)IBA
11/2010
1AntioxidantsIBA
06/2006
1Pergolide (Permax)FDA Link
02/2005
1Dopamine Agents (Dopaminergic Agents)IBA
01/2005
1entacapone (Comtan)FDA Link
09/2004
1Pregnanolone (Allopregnanolone)IBA
10/2003
1NeurosteroidsIBA
10/2003
1Amantadine (Aman)FDA LinkGeneric
01/2002
1gamma-Aminobutyric Acid (GABA)IBA
02/2001
1Amino AcidsFDA Link
02/2001
1Glutamic Acid (Glutamate)FDA Link
02/2001
1Immunoglobulin G (IgG)IBA
02/2001
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2001
1Aspartic Acid (Aspartate)FDA Link
02/2001

Therapy/Procedure

8Deep Brain Stimulation
05/2011 - 02/2001
3Therapeutics
01/2005 - 02/2001
2Transcranial Magnetic Stimulation
10/2004 - 11/2001
1Sympathectomy (Sympathectomies)
12/2012